These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 27580354

  • 21. Identification of proteins associated with lymph node metastasis of gastric cancer.
    Ma Y, Li YF, Wang T, Pang R, Xue YW, Zhao SP.
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1739-49. PubMed ID: 24828259
    [Abstract] [Full Text] [Related]

  • 22. Pilot research for the correlation between the expression pattern of E-cadherin-β-catenin complex and lymph node metastasis in early gastric cancer.
    Yoshii T, Miyagi Y, Nakamura Y, Kobayashi O, Kameda Y, Ohkawa S.
    Tumori; 2013 Oct; 99(2):234-8. PubMed ID: 23748820
    [Abstract] [Full Text] [Related]

  • 23. Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/β-catenin signaling.
    Qiu HB, Zhang LY, Ren C, Zeng ZL, Wu WJ, Luo HY, Zhou ZW, Xu RH.
    PLoS One; 2013 Oct; 8(3):e56959. PubMed ID: 23554857
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of CDH17 gene expression via RNA interference reduces proliferation and apoptosis of human MKN28 gastric cancer cells.
    Li R, Yang HQ, Xi HL, Feng S, Qin RH.
    Int J Oncol; 2017 Jan; 50(1):15-22. PubMed ID: 27909714
    [Abstract] [Full Text] [Related]

  • 25. Analysis of a cytoskeleton-associated kinase PEAK1 and E-cadherin in gastric cancer.
    Guo Q, Qin W, Li B, Yang H, Guan J, Liu Z, Li S.
    Pathol Res Pract; 2014 Dec; 210(12):793-8. PubMed ID: 25445115
    [Abstract] [Full Text] [Related]

  • 26. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
    Fleischmann A, Rotzer D, Seiler R, Studer UE, Thalmann GN.
    Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
    [Abstract] [Full Text] [Related]

  • 27. Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.
    Lee HJ, Nam KT, Park HS, Kim MA, Lafleur BJ, Aburatani H, Yang HK, Kim WH, Goldenring JR.
    Gastroenterology; 2010 Jul; 139(1):213-25.e3. PubMed ID: 20398667
    [Abstract] [Full Text] [Related]

  • 28. Clinicopathological and prognostic significance of immunophenotypic characterization of endocervical adenocarcinoma using CLDN18, CDH17, and PAX8 in association with HPV status.
    Asaka S, Nakajima T, Ida K, Asaka R, Kobayashi C, Ito M, Miyamoto T, Uehara T, Ota H.
    Virchows Arch; 2022 Feb; 480(2):269-280. PubMed ID: 34581850
    [Abstract] [Full Text] [Related]

  • 29. Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer.
    Xiangming C, Hokita S, Natsugoe S, Tanabe G, Baba M, Takao S, Kuroshima K, Aikou T.
    Oncology; 1999 Feb; 57(2):131-7. PubMed ID: 10461060
    [Abstract] [Full Text] [Related]

  • 30. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY, Ye ZY, Zhao ZS, Tao HQ, Chu YQ.
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [Abstract] [Full Text] [Related]

  • 31. The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer.
    Suh YS, Lee HJ, Jung EJ, Kim MA, Nam KT, Goldenring JR, Yang HK, Kim WH.
    Ann Surg Oncol; 2012 Apr; 19(4):1240-9. PubMed ID: 22048633
    [Abstract] [Full Text] [Related]

  • 32. MiR 21-5p as a predictor of recurrence in young gastric cancer patients.
    Park SK, Park YS, Ahn JY, Do EJ, Kim D, Kim JE, Jung K, Byeon JS, Ye BD, Yang DH, Park SH, Hwang SW, Jung HY, Myung SJ.
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1429-35. PubMed ID: 26824898
    [Abstract] [Full Text] [Related]

  • 33. [Claudins as prognostic factors of breast cancer].
    Szász MA.
    Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
    [Abstract] [Full Text] [Related]

  • 34. HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions.
    Fusco N, Rocco EG, Del Conte C, Pellegrini C, Bulfamante G, Di Nuovo F, Romagnoli S, Bosari S.
    Mod Pathol; 2013 Jun; 26(6):816-24. PubMed ID: 23348899
    [Abstract] [Full Text] [Related]

  • 35. [Metastasis rates of lymph nodes and distribution in advanced gastric cancer and its clinical significance].
    Nzengue JC, Zhan WH, Wang JP, Dong WG, Lan P, He YL, Chen ZX, Cai SR.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):506-9. PubMed ID: 17143796
    [Abstract] [Full Text] [Related]

  • 36. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR, Sun Z, Zhu Z, Guan HX, Li CY, Zhang JY, Zhang YN, Zhou H, Zhang HJ, Xu HM, Sun MJ.
    World J Gastroenterol; 2015 May 07; 21(17):5336-44. PubMed ID: 25954108
    [Abstract] [Full Text] [Related]

  • 37. Claudin-18.2 mediated interaction of gastric Cancer cells and Cancer-associated fibroblasts drives tumor progression.
    Liu S, Zhang Z, Jiang L, Zhang M, Zhang C, Shen L.
    Cell Commun Signal; 2024 Jan 10; 22(1):27. PubMed ID: 38200591
    [Abstract] [Full Text] [Related]

  • 38. Whole-transcriptome sequencing in advanced gastric or gastroesophageal cancer: A deep dive into its clinical potential.
    Hashimoto T, Nakamura Y, Mishima S, Nakayama I, Kotani D, Kawazoe A, Kuboki Y, Bando H, Kojima T, Iida N, Shibuki T, Imai M, Fujisawa T, Nagamine M, Sakamoto N, Kuwata T, Yoshino T, Shitara K.
    Cancer Sci; 2024 May 10; 115(5):1622-1633. PubMed ID: 38429886
    [Abstract] [Full Text] [Related]

  • 39. Expression of peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases.
    He Q, Chen J, Lin HL, Hu PJ, Chen MH.
    Chin Med J (Engl); 2007 Sep 05; 120(17):1498-504. PubMed ID: 17908458
    [Abstract] [Full Text] [Related]

  • 40. Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults.
    Nakayama I, Shinozaki E, Sakata S, Yamamoto N, Fujisaki J, Muramatsu Y, Hirota T, Takeuchi K, Takahashi S, Yamaguchi K, Noda T.
    Cancer Sci; 2019 Apr 05; 110(4):1352-1363. PubMed ID: 30771244
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.